In the analysis of eight ovarian cancer cohorts, including in total 395 patients when discarding event times shorter than three years, only one late-type gene (RPS6) showed a significant association with OS and only in one cohort (S7C Table), higher gene expression being associated with better outcome, in agreement with the observed association with longer MFS in breast cancer. This evidence concerns the gene RPS6 and ovarian cancer.